{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:49:20Z","timestamp":1789044560499,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.yebeh.2025.110751","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T23:31:29Z","timestamp":1760657489000},"page":"110751","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Effectiveness and safety of clobazam as add-on therapy in children after the failure of first antiseizure medicine: a sub-analysis of the ADD-ON study"],"prefix":"10.1016","volume":"173","author":[{"given":"Parthasarathy","family":"Satishchandra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5567-1715","authenticated-orcid":false,"given":"Chaturbhuj","family":"Rathore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anirudha","family":"Apte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amlan","family":"Mandal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bindu","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dushyant","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagadish","family":"Agadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayanti","family":"Gurumukhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Asokan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Ramadoss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Venkateshwarlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lokesh","family":"Lingappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Malokar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagarjunakonda Venkata","family":"Sundaracharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pahari","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangeeta","family":"Ravat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev","family":"VK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddhartha","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhir K","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhir Vadilal","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundaram","family":"Alagesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushil","family":"Razdan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uma","family":"Padhy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay Kumar","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvind","family":"Gadekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6995-9791","authenticated-orcid":false,"given":"Afnan","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7802-1875","authenticated-orcid":false,"given":"Kedar","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepa","family":"Chodankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunny","family":"Chinchansurkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0419-8766","authenticated-orcid":false,"given":"Avinash","family":"Arivazhahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalini","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nivedita","family":"Telang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"S5","key":"10.1016\/j.yebeh.2025.110751_b0005","first-page":"S2","article-title":"Staged approach to epilepsy management","volume":"58","author":"Brodie","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2025.110751_b0010","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2174\/157015909788848866","article-title":"Antiepileptic drug monotherapy: the initial approach in epilepsy management","volume":"7","author":"St Louis","year":"2009","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.yebeh.2025.110751_b0015","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1001\/jamaneurol.2017.3949","article-title":"Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs: a 30-Year longitudinal cohort study","volume":"75","author":"Chen","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.yebeh.2025.110751_b0020","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/epi.17573","article-title":"Should substitution monotherapy or combination therapy be used after failure of the first antiseizure medication? Observations from a 30-year cohort study","volume":"64","author":"Hakeem","year":"2023","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2025.110751_b0025","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.2165\/00003495-200666140-00004","article-title":"Combination therapy in epilepsy: when and what to use","volume":"66","author":"Kwan","year":"2006","journal-title":"Drugs"},{"key":"10.1016\/j.yebeh.2025.110751_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2022.108671","article-title":"Evaluation of one-year effectiveness of clobazam as an add-on therapy to anticonvulsant monotherapy in participants with epilepsy having uncontrolled seizure episodes: an Indian experience","volume":"130","author":"Satishchandra","year":"2022","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2025.110751_b0035","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1517\/14656566.2012.647686","article-title":"Clobazam for treatment of epilepsy","volume":"13","author":"Giarratano","year":"2012","journal-title":"Expert OpinPharmacother"},{"issue":"2","key":"10.1016\/j.yebeh.2025.110751_b0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088456","article-title":"Clobazam and its active metabolite N-desmethylclobazam display significantly greater affinities for \u03b12- versus \u03b11-GABA(A)-receptor complexes","volume":"9","author":"Jensen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.yebeh.2025.110751_b0045","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/0883073812463609","article-title":"Clobazam: a newly approved but well-established drug for the treatment of intractable epilepsy syndromes","volume":"28","author":"Wheless","year":"2013","journal-title":"J Child Neurol"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110751_b0050","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.pediatrneurol.2014.01.025","article-title":"Clobazam: effect on frequency of seizures and safety profile in different subgroups of children with epilepsy","volume":"51","author":"Klehm","year":"2014","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2025.110751_b0055","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0887-8994(93)90026-9","article-title":"Open study of clobazam in refractory epilepsy","volume":"9","author":"Munn","year":"1993","journal-title":"Pediatr Neurol"},{"issue":"3B","key":"10.1016\/j.yebeh.2025.110751_b0060","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1590\/S0004-282X2006000500001","article-title":"Effectiveness of clobazam as add-on therapy in children with refractory focal epilepsy","volume":"64","author":"da Silveira","year":"2006","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.yebeh.2025.110751_b0065","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1212\/WNL.0b013e318232de76","article-title":"Randomized, phase III study results of clobazam in Lennox-Gastaut syndrome","volume":"77","author":"Ng","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2025.110751_b0070","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/0883073812461943","article-title":"Clobazam for the treatment of intractable epilepsy in children","volume":"28","author":"Perry","year":"2013","journal-title":"J Child Neurol"},{"key":"10.1016\/j.yebeh.2025.110751_b0075","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/epi.13670","article-title":"Operational classification of seizure types by the International League against Epilepsy: position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Fisher","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2025.110751_b0080","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2025.110751_b0085","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/WNF.0b013e31815cd960","article-title":"Efficacy of clobazam as add-on therapy for refractory epilepsy: experience at a US epilepsy center","volume":"31","author":"Montenegro","year":"2008","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.yebeh.2025.110751_b0090","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0920-1211(96)01007-8","article-title":"Lamotrigine substitution study: evidence for synergism with sodium valproate? 105 Study Group","volume":"26","author":"Brodie","year":"1997","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2025.110751_b0095","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.yebeh.2018.01.001","article-title":"Efficacy and tolerability of perampanel and levetiracetam as first add-on therapy in patients with epilepsy: a retrospective single center study","volume":"80","author":"Liguori","year":"2018","journal-title":"Epilepsy Behav"},{"issue":"2","key":"10.1016\/j.yebeh.2025.110751_b0100","first-page":"209","article-title":"Effect of clobazam as add-on antiepileptic drug in patients with epilepsy","volume":"140","author":"Joshi","year":"2014","journal-title":"Indian J Med Res"},{"issue":"3","key":"10.1016\/j.yebeh.2025.110751_b0105","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s12098-010-0035-z","article-title":"Clobazam in refractory childhood epilepsy","volume":"77","author":"Kalra","year":"2010","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.yebeh.2025.110751_b0110","first-page":"284","article-title":"Long-term use of clobazam in the management of intractable epilepsy: a prospective study","volume":"46","author":"Satishchandra","year":"1998","journal-title":"Neurol India"},{"issue":"4","key":"10.1016\/j.yebeh.2025.110751_b0115","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.yebeh.2012.09.039","article-title":"Long-term safety and efficacy of clobazam for Lennox-Gastaut syndrome: Interim results of an open-label extension study","volume":"25","author":"Ng","year":"2012","journal-title":"Epilepsy Behav"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505025004913?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505025004913?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T17:44:34Z","timestamp":1763747074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505025004913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":23,"alternative-id":["S1525505025004913"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2025.110751","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness and safety of clobazam as add-on therapy in children after the failure of first antiseizure medicine: a sub-analysis of the ADD-ON study","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2025.110751","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110751"}}